- Home
- VRCA vs APYX Comparison
VRCA vs APYX Comparison
Compare VRCA & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRCA
- APYX
- Stock Information
- Founded
- VRCA 2013
- APYX 1982
- Country
- VRCA United States
- APYX United States
- Employees
- VRCA N/A
- APYX N/A
- Industry
- VRCA Biotechnology: Pharmaceutical Preparations
- APYX Medical/Dental Instruments
- Sector
- VRCA Health Care
- APYX Health Care
- Exchange
- VRCA Nasdaq
- APYX Nasdaq
- Market Cap
- VRCA 80.7M
- APYX 85.0M
- IPO Year
- VRCA 2018
- APYX 1987
- Fundamental
- Price
- VRCA $5.99
- APYX $1.90
- Analyst Decision
- VRCA Hold
- APYX Hold
- Analyst Count
- VRCA 5
- APYX 2
- Target Price
- VRCA $6.00
- APYX N/A
- AVG Volume (30 Days)
- VRCA 57.3K
- APYX 117.8K
- Earning Date
- VRCA 08-13-2025
- APYX 08-07-2025
- Dividend Yield
- VRCA N/A
- APYX N/A
- EPS Growth
- VRCA N/A
- APYX N/A
- EPS
- VRCA N/A
- APYX N/A
- Revenue
- VRCA $7,179,000.00
- APYX $47,288,000.00
- Revenue This Year
- VRCA $165.25
- APYX $2.25
- Revenue Next Year
- VRCA $80.06
- APYX $6.76
- P/E Ratio
- VRCA N/A
- APYX N/A
- Revenue Growth
- VRCA N/A
- APYX N/A
- 52 Week Low
- VRCA $3.82
- APYX $0.76
- 52 Week High
- VRCA $71.40
- APYX $2.73
- Technical
- Relative Strength Index (RSI)
- VRCA 38.77
- APYX 42.72
- Support Level
- VRCA $5.86
- APYX $2.20
- Resistance Level
- VRCA $7.13
- APYX $2.70
- Average True Range (ATR)
- VRCA 0.88
- APYX 0.26
- MACD
- VRCA -0.28
- APYX -0.05
- Stochastic Oscillator
- VRCA 6.01
- APYX 20.00
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.